Publications, Pharmaceutical

Investigation of Powder Blend Uniformity and Deposition in a Nasal Cast Using a Unit Dose Nasal Device

Interest is increasing in the use of powder formulations for nasal deposition for pain relief, disorders of the central nervous systems and vaccination. This article describes an experimental study of the deposition behavior of different blends of sumatriptan, a drug used for the treatment of migraine, with a unit dose nasal device. Blends were formulated using different lactose grades, with and without magnesium stearate, and delivered to a validated nasal cast (use courtesy of Aptar Pharma/DTF/Univ. of Tours) using a proprietary unit dose nasal device from Aptar Pharma. The results show that despite differences in cohesivity successful deposition was achieved with all model formulations at target sites such as the turbinates and olfactory region. The results demonstrate the potential utility of the unit dose nasal device.

Download Publication
1 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

5 Jan 2023

Case Study – Unidose Nasal Spray Pump for Epilepsy

Case Studies, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
14 Dec 2022

Building Digital Solutions To Meet The Unique Therapeutic Needs o...

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
30 Nov 2022

Drug Repositioning – Benefits and Challenges for Lifecycle Mana...

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
24 Nov 2022

Step to Success in Nose-to-Brain Drug Delivery

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
1 2 3 18
Back To Top